Prostate cancer is the most common non-cutaneous malignancy afflicting men in the United States. Indeed, since the incidence of prostate cancer increases with age, as Americans enjoy longer lives, the impact of prostate cancer will continue to rise. The availability of sensitive methods for screening has increased the frequency of diagnoses, leading to an explosion in the utilization of surgical, radiation, and systemic treatments and a tremendous need for stratifying patients appropriately. Coupled with the discovery of many potential new drug targets, the need for interactions between laboratory, clinical, and population researchers has never been more pressing.To this end, The Dean and Betty Gallo Prostate Cancer Center (GPCC) was established with the goal of eradicating prostate cancer and improving the lives of men at risk for the disease through research, treatment, education, and prevention. GPCC was founded in the memory of Dean Gallo, a beloved New Jersey Congressman who died tragically of prostate cancer diagnosed at an advanced stage. GPCC unites a team of outstanding researchers and clinicians who are committed to high-quality basic research, translation of innovative research to the clinic, exceptional patient care, and improving public education and awareness of prostate cancer. GPCC, as part of The Cancer Institute of New Jersey (CINJ), which is the only National Cancer Institute-designated cancer center in the state, has focused its efforts on three major areas: (i) Basic, Clinical, Translational, and Population Research, (ii) Comprehensive Patient Care, and (iii) Education and Outreach.The purpose of this proposal is to provide research services that will contribute significantly to progress in the diagnosis, prevention, and treatment of prostate cancer. These goals will be accomplished through the infrastructure support of a Biospecimen/Data Repository, which will contribute uniquely to the prostate research program and facilitate the rapid translation of basic and population-based research to clinical and preventive applications.The goal of this proposal is to continue and to further develop GPCC as a multidisciplinary center to study all aspects of prostate cancer and its prevention.
|Effective start/end date||8/1/10 → 1/31/15|
- Congressionally Directed Medical Research Programs (CDMRP)